tiprankstipranks
Trending News
More News >
Rocket Pharmaceuticals (DE:9IP1)
FRANKFURT:9IP1
Germany Market

Rocket Pharmaceuticals (9IP1) Technical Analysis

Compare
3 Followers

Summary of all the Indicators

Overall Consensus
Buy
14Bullish
3Neutral
4Bearish
Technical Analysis Consensus
Sell
2Bullish
3Neutral
4Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Rocket Pharmaceuticals’s (9IP1) Moving Averages Convergence Divergence (MACD) indicator is 0.36, suggesting Rocket Pharmaceuticals is a Sell.
Rocket Pharmaceuticals’s (9IP1) 20-Day exponential moving average is 3.56, while Rocket Pharmaceuticals’s (9IP1) share price is €4.28, making it a Buy.
Rocket Pharmaceuticals’s (9IP1) 50-Day exponential moving average is 3.18, while Rocket Pharmaceuticals’s (9IP1) share price is €4.28, making it a Buy.

Rocket Pharmaceuticals (9IP1) Pivot Points

Mar 15, 2026, 08:04 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
4.22
4.22
4.22
4.22
4.22
4.22
4.22
Fibonacci
4.22
4.22
4.22
4.22
4.22
4.22
4.22
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Rocket Pharmaceuticals (9IP1) Moving Averages

Mar 15, 2026, 08:04 AM
Period
Simple
Exponential
MA5
4.00Buy
4.09Buy
MA10
3.92Buy
3.88Buy
MA20
3.38Buy
3.56Buy
MA50
3.06Buy
3.18Buy
MA100
2.90Buy
3.05Buy
MA200
2.72Buy
3.28Buy
Rocket Pharmaceuticals’s (9IP1) 10-Day exponential moving average is 3.88, while Rocket Pharmaceuticals’s (9IP1) share price is €4.28, making it a Buy.
Rocket Pharmaceuticals’s (9IP1) 100-Day exponential moving average is 3.05, while Rocket Pharmaceuticals’s (9IP1) share price is €4.28, making it a Buy.
Rocket Pharmaceuticals’s (9IP1) stock price is €4.28 and Rocket Pharmaceuticals’s (9IP1) 50-day simple moving average is 3.06, creating a Buy signal.
Rocket Pharmaceuticals’s (9IP1) stock price is €4.28 and Rocket Pharmaceuticals’s (9IP1) 100-day simple moving average is 2.90, creating a Buy signal.
Rocket Pharmaceuticals’s (9IP1) stock price is €4.28 and Rocket Pharmaceuticals’s (9IP1) 200-day simple moving average is 2.72, creating a Buy signal.

Rocket Pharmaceuticals (9IP1) Technical Indicators

Mar 15, 2026, 08:04 AM
Name
Value
Implied Action
RSI (14)
70.25
Sell
STOCH (9,6)
76.26
Neutral
STOCHRSI (14)
88.92
Sell
MACD (12,26)
0.36
Sell
ADX (14)
41.10
Neutral
Williams %R
0.00
Buy
CCI (14)
123.15
Sell
ATR (14)
0.19
-
Ultimate Oscillator
65.71
Neutral
ROC
62.50
Buy
Rocket Pharmaceuticals’s (9IP1) Relative Strength Index (RSI) is 70.25, creating a Sell signal.
Rocket Pharmaceuticals’s (9IP1) Trend Strength Indicator (ADX) is 41.10, creating a Neutral signal.
Rocket Pharmaceuticals’s (9IP1) Commodity Channel Index (CCI) is 123.15, creating a Sell signal.
Rocket Pharmaceuticals’s (9IP1) Price Rate of Change (ROC) is 62.50, creating a Buy signal.

FAQ

Is 9IP1 a Buy, Hold, or Sell?
Based on 9IP1’s technical indicators, 9IP1 is a Buy.
    What is 9IP1’s RSI (14)?
    9IP1’s RSI (14) is 70.25, which suggests 9IP1 is a Sell.
      What is 9IP1’s MACD?
      9IP1’s MACD is 0.36, which suggests 9IP1 is a Sell.
        What is 9IP1’s 5-day moving average?
        9IP1’s 5-day moving average is 4.00, which suggests 9IP1 is a Buy.
          What is 9IP1’s 20-day moving average?
          9IP1 20-day moving average is 3.38, which suggests 9IP1 is a Buy.
            What is 9IP1’s 50-day moving average?
            9IP1’s 50-day moving average is 3.06, which suggests 9IP1 is a Buy.
              What is 9IP1’s 200-day moving average?
              9IP1’s 200-day moving average is 2.72, which suggests 9IP1 is a Buy.
                What is 9IP1’s Williams % R (14)?
                9IP1’s Williams % R (14) is 0.00, which suggests 9IP1 is a Buy.
                  What is 9IP1’s CCI (14)?
                  9IP1’s CCI (14) is 123.15, which suggests 9IP1 is a Sell.
                    What is the share price of Rocket Pharmaceuticals?